The common cold: A review of the literature

European Journal of Internal Medicine

Volumn 15, Issue 2, 2004, Pages 79-88

  Wat, Dennis ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Common cold; Influenza; Respiratory syncytial virus; Rhinovirus

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; ANTIHISTAMINIC AGENT; ASCORBIC ACID; DECONGESTIVE AGENT; ECHINACEA EXTRACT; INFLUENZA VACCINE; INTERFERON; IPRATROPIUM BROMIDE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; OSELTAMIVIR; PALIZIVUMAB; PARAINFLUENZA VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ZANAMIVIR; ZINC;

ADENOVIRUS; ANTIBODY DETECTION; ANTIGEN DETECTION; CLINICAL FEATURE; COMMON COLD; CONCENTRATION LOSS; CORONAVIRUS; CYTOPATHOGENIC EFFECT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS; INSOMNIA; IRRITABILITY; LOZENGE; METAPNEUMOVIRUS; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; NOSE OBSTRUCTION; PALLIATIVE THERAPY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; SARS CORONAVIRUS; SERODIAGNOSIS; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; TISSUE CULTURE; VACCINATION; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS PNEUMONIA; VIRUS TRANSMISSION;

EID: 2542448163     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.01.006     Document Type: Review

References (102)

1. Johnston S.L., Pattemore P.K., Sanderson G., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 310(6989):1995;1225-1229
2. Seemungal T., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164(9):2001;1618-1623
3. Hiatt P.W., Grace S.C., Kozinetz C.A., Raboudi S.H., Treece D.G., Taber L.H., Piedra P.A. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatr. 103:1999;619-626
4. Wang E.E., Prober C.G., Manson B., Corey M., Levison H. Associations of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N. Eng. J. Med. 311:1984;1653-1658
5. Prober C.G. The impact of respiratory viral infections in patients with cystic fibrosis. Clin. Rev. Allergy. 9:1991;87-102
6. Gwaltney J.M. Jr., Moskalski P.B., Hendley J.O. Hand-to-hand transmission of rhinovirus colds. Ann. Intern. Med. 88(4):1978;463-467
7. Meschievitz C.K., Schultz S.B., Dick E.C. A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J. Infect. Dis. 150(2):1984;195-201
8. Smith C.B., Purcell R.H., Bellanti J.A., Chanock R.M. Protective effect of antibody to parainfluenza type 1 virus. N. Engl. J. Med. 275(21):1966;1145- 1152
9. Nicholson K. Human influenza. Nicholson K.G.W.R., Hay A.J. Textbook of influenza. 1998;219-264 Blackwell, Oxford
10. Pelon W., Mogabgab W., Philips I., et al. A cytopathic agent isolated from nasal recruits and mild respiratory illness. Proc. Soc. Exp. Biol. Med. 94:1957;262-267
11. Price W. The isolation of the new virus associated with respiratory clincal disease in humans. Proc. Natl. Acad. Sci. U. S. A. 42:1956;892-896
12. Monto A.S., Bryan E.R., Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J. Infect. Dis. 156(1):1987;43-49
13. Beem M.O. Acute respiratory illness in nursery school children: a longitudinal study of the occurrence of illness and respiratory viruses. Am. J. Epidemiol. 90(1):1969;30-44
14. Hendley J.O., Gwaltney J.M. Jr., Jordan W.S. Jr. Rhinovirus infections in an industrial population: IV. Infections within families of employees during two fall peaks of respiratory illness. Am. J. Epidemiol. 89(2):1969;184-196
15. Lewis V.A., Champlin R., Englund J., et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin. Infect. Dis. 23(5):1996;1033-1037
16. Heidemann S.M. Clinical characteristics of parainfluenza virus infection in hospitalized children. Pediatr. Pulmonol. 13(2):1992;86-89
17. Korppi M., Leinonen M., Makela P.H., Launiala K. Bacterial involvement in parainfluenza virus infection in children. Scand. J. Infect. Dis. 22(3):1990;307-312
18. Makela M.J., Puhakka T., Ruuskanen O., et al. Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 36(2):1998;539-542
19. Larson H.E., Reed S.E., Tyrrell D.A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 5(3):1980;221-229
20. Nicholson K.G., Kent J., Hammersley V., Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 315(7115):1997;1060-1064
21. Callow K.A., Parry H.F., Sergeant M., Tyrrell D.A. The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect. 105(2):1990;435-446
22. Zeng F.Y., Chan C.W., Chan M.N., et al. The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39). Exp. Biol. Med. 228(7):2003;866-873. [Maywood]
23. Whitby N., Whitby M. SARS: a new infectious disease for a new century. Aust. Fam. Physician. 32(10):2003;779-783
24. Moser M.R., Bender T.R., Margolis H.S., Noble G.R., Kendal A.P., Ritter D.G. An outbreak of influenza aboard a commercial airliner. Am. J. Epidemiol. 110(1):1979;1-6
25. Loosli C., Lemon H., Oh R., et al. Experimental airborn influenza infection: I. Influenza of humidity on survival of virus in air. Proc. Soc. Exp. Biol. Med. 53:1943;205-206
26. Suarez D.L., Perdue M.L., Cox N., et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72(8):1998;6678-6688
27. Claas E.C., Osterhaus A.D., vanBeek R., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351(9101):1998;472-477
28. Zhou N.N., Shortridge K.F., Claas E.C., Krauss S.L., Webster R.G. Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J. Virol. 73(4):1999;3366-3374
29. Parrott R.H., Kim H.W., Brandt C.D., Chanock R.M. Respiratory syncytial virus in infants and children. Prev. Med. 3(4):1974;473-480
30. Rave W., Heubner R., Gilmore L., et al. Isolation of cytpopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 84:1953;570-573
31. Hierholzer J.C., Wigand R., Anderson L.J., Adrian T., Gold J.W. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J. Infect. Dis. 158(4):1988;804-813
32. Finn A., Anday E., Talbot G.H. An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management. Infect. Control Hosp. Epidemiol. 9(9):1988;398-404
33. Brandt C.D., Kim H.W., Vargosko A.J., et al. Infections in 18, 000 infants and children in a controlled study of respiratory tract disease: I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am. J. Epidemiol. 90(6):1969;484-500
34. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7(6):2001;719-724
35. Peret T.C., Boivin G., Li Y., et al. Characterization of human metapneumoviruses isolated from patients in North America. J. Infect. Dis. 185(11):2002;1660-1663
36. Nissen M.D., Siebert D.J., Mackay I.M., Sloots T.P., Withers S.J. Evidence of human metapneumovirus in Australian children. Med. J. Aust. 176(4):2002;188
37. Arruda E., Pitkaranta A., Witek T.J. Jr., Doyle C.A., Hayden F.G. Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol. 35(11):1997;2864-2868
38. Winther B., Gwaltney J.M. Jr., Mygind N., Turner R.B., Hendley J.O. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 256(13):1986;1763-1767
39. Fraenkel D.J., Bardin P.G., Sanderson G., Lampe F., Johnston S.L., Holgate S.T. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am. J. Respir. Crit. Care Med. 150(4):1994;1130-1136
40. Winther B. Effects on the nasal mucosa of upper respiratory viruses (common cold). Dan. Med. Bull. 41(2):1994;193-204
41. Noah T.L., Henderson F.W., Wortman I.A., et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 171(3):1995;584-592
42. Fritz R.S., Hayden F.G., Calfee D.P., et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J. Infect. Dis. 180(3):1999;586-593
43. Naclerio R.M., Proud D., Lichtenstein L.M., et al. Kinins are generated during experimental rhinovirus colds. J. Infect. Dis. 157(1):1988;133-142
44. Turner R.B., Weingand K.W., Yeh C.H., Leedy D.W. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin. Infect. Dis. 26(4):1998;840-846
45. Zhu Z., Tang W., Ray A., et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Invest. 97(2):1996;421-430
46. Schmidt O.W. Antigenic characterization of human coronaviruses 229E and OC43 by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 20(2):1984;175-180
47. Schmidt O.W., Kenny G.E. Immunogenicity and antigenicity of human coronaviruses 229E and OC43. Infect. Immun. 32(3):1981;1000-1006
48. Yeager C.L., Ashmun R.A., Williams R.K., et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 357(6377):1992;420-422
49. Kunkel F., Herrler G. Structural and functional analysis of the S proteins of two human coronavirus OC43 strains adapted to growth in different cells. Arch. Virol. 141(6):1996;1123-1131
50. Tyrrell D.A., Cohen S., Schlarb J.E. Signs and symptoms in common colds. Epidemiol. Infect. 111(1):1993;143-156
51. Reed S.E. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J. Med. Virol. 13(2):1984;179-192
52. Bradburne A.F., Bynoe M.L., Tyrrell D.A. Effects of a "new" human respiratory virus in volunteers. Br. Med. J. 3(568):1967;767-769
53. Hers J.F. Disturbances of the ciliated epithelium due to influenza virus. Am. Rev. Respir. Dis. 93(3 Suppl):1966;162-177
54. Hers J.F., Mulder J. Broad aspects of the pathology and pathogenesis of human influenza. Am. Rev. Respir. Dis. 83(2 Pt 2):1961;84-97
55. Walsh J.J., Dietlein L.F., Low F.N., Burch G.E., Mogabgab W.J. Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch. Intern. Med. 108:1961;376-388
56. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101(3):1998;643-649
57. Eichelberger M.C., Wang M.L., Allan W., Webster R.G., Doherty P.C. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 72(Pt 7):1991;1695-1698
58. Neilson K.A., Yunis E.J. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr. Pathol. 10(4):1990;491-502
59. Tristram D.A., Hicks W. Jr., Hard R. Respiratory syncytial virus and human bronchial epithelium. Arch. Otolaryngol. Head Neck Surg. 124(7):1998;777-783
60. Hall C.B., Douglas R.G. Jr., Simons R.L. Interferon production in adults with respiratory syncytial viral infection. Ann. Intern. Med. 94(1):1981;53-55
61. Lilic D., Cant A.J., Abinun M., Calvert J.E., Spickett G.P. Cytokine production differs in children and adults. Pediatr. Res. 42(2):1997;237-240
62. Stockton J., Stephenson I., Fleming D., Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg. Infect. Dis. 8(9):2002;897-901
63. Welliver R.C., Wong D.T., Middleton E. Jr., Sun M., McCarthy N., Ogra P.L. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J. Pediatr. 101(6):1982;889-896
64. Nutting P.A., Main D.S., Fischer P.M., et al. Toward optimal laboratory use. Problems in laboratory testing in primary care. JAMA. 275(8):1996;635-639
65. Covalciuc K.A., Webb K.H., Carlson C.A. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods. J. Clin. Microbiol. 37(12):1999;3971-3974
66. Hall C.B., Douglas R.G. Jr. Clinically useful method for the isolation of respiratory syncytial virus. J. Infect. Dis. 131(1):1975;1-5
67. Schmid M.L., Kudesia G., Wake S., Read R.C. Prospective comparative study of culture specimens and methods in diagnosing influenza in adults. BMJ. 316(7127):1998;275
68. Heikkinen T., Marttila J., Salmi A.A., Ruuskanen O. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J. Clin. Microbiol. 40(11):2002;4337-4339
69. Corne J.M., Green S., Sanderson G., Caul E.O., Johnston S.L. A multiplex RT-PCR for the detection of parainfluenza viruses 1-3 in clinical samples. J. Virol. Methods. 82(1):1999;9-18
70. Hamparian V.V., Colonno R.J., Cooney M.K., et al. A collaborative report: rhinoviruses-extension of the numbering system from 89 to 100. Virology. 159(1):1987;191-192
71. Compton J. Nucleic acid sequence-based amplification. Nature. 350(6313):1991;91-92
72. Kievits T., van Gemen B., van Strijp D., et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods. 35(3):1991;273-286
73. Guatelli J.C., Whitfield K.M., Kwoh D.Y., Barringer K.J., Richman D.D., Gingeras T.R. Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. Proc. Natl. Acad. Sci. U. S. A. 87(19):1990;7797
74. Leone G., van Schijndel H., van Gemen B., Kramer F.R., Schoen C.D. Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time detection of RNA. Nucleic Acids Res. 26(9):1998;2150-2155
75. Swierkosz E.M., Erdman D.D., Bonnot T., Schneiderheinze C., Waner J.L. Isolation and characterization of a naturally occurring parainfluenza 3 virus variant. J. Clin. Microbiol. 33(7):1995;1839-1841
76. Fan J., Henrickson K.J., Savatski L.L. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin. Infect. Dis. 26(6):1998;1397-1402
77. Kehl S.C., Henrickson K.J., Hua W., Fan J. Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J. Clin. Microbiol. 39(5):2001;1696-1701
78. Fleming D.M. The impact of three influenza epidemics on primary care in England and Wales. Pharmacoeconomics. 9(Suppl 3):1996;38-45. [discussion 50-53]
79. Douglas R.M., Moore B.W., Miles H.B., et al. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N. Engl. J. Med. 314(2):1986;65-70
80. Kim H.W., Canchola J.G., Brandt C.D., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89(4):1969;422-434
81. Group. TIRS Palivizumab, a humanised respiratory syncytial virus monoclonal antibody reduces hospitalisation from respiratory syncytial virus infection in high risk infants. Paediatrics. 102:1998;531-537
82. Schmidt A.C., McAuliffe J.M., Murphy B.R., Collins P.L. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. J. Virol. 75(10):2001;4594-4603
83. Douglas R.M., Chalker E.B., Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev. (2):2000;. [CD000980]
84. Giles J.T., Palat C.T. III, Chien S.H., Chang Z.G., Kennedy D.T. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 20(6):2000;690-697
85. Marshall I. Zinc for the common cold. Cochrane Database Syst, Rev. (2):2000;. [CD001364]
86. Macknin M.L., Piedmonte M., Calendine C., Janosky J., Wald E. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA. 279(24):1998;1962-1967
87. Belongia E.A., Berg R., Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am. J. Med. 111(2):2001;103-108
88. Mossad S.B. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 96(1):2003;35-43
89. Sperber S.J., Sorrentino J.V., Riker D.K., Hayden F.G. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull. N. Y. Acad. Med. 65(1):1989;145-160
90. Taverner D., Bickford L., Draper M. Nasal decongestants for the common cold. Cochrane Database Syst. Rev. (2):2000;. [CD001953]
91. Gwaltney J.M. Jr., Druce H.M. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin. Infect. Dis. 25(5):1997;1188-1194
92. Diamond L., Dockhorn R.J., Grossman J., et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J. Allergy Clin. Immunol. 95(5 Pt 2):1995;1139-1146
93. Sperber S.J., Hendley J.O., Hayden F.G., Riker D.K., Sorrentino J.V., Gwaltney J.M. Jr. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann. Intern. Med. 117(1):1992;37-41
94. Gwaltney J.M. Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J. Infect. Dis. 166(4):1992;776-782
95. Nicholson K.G., Aoki F.Y., Osterhaus A.D., et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 355(9218):2000;1845-1850
96. Group. TMS Randomised trial of efficacy and safety of inhaled Zanamivir in the treatment of influenza A and B virus infections. Lancet. 352:1998;1845-1850
97. Hayden F.G., Treanor J.J., Betts R.F., Lobo M., Esinhart J.D., Hussey E.K. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 275(4):1996;295-299
98. Diseases CoI Use of ribavarin in the treatment of respiratory syncytial virus infection. Pediatrics. 92:1993;501-504
99. Rosner I.K., Welliver R.C., Edelson P.J., Geraci-Ciardullo K., Sun M. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. J. Infect. Dis. 155(5):1987;1043-1047
100. Hiatt P.T., Laber D.L. Pulmonary function (PF) following treatment with ribavarin in infants hospitalised with RSV bronchiolitis. Am. Rev. Respir. Dis. 141:1990;A624
101. Smith D.W., Frankel L.R., Mathers L.H., Tang A.T., Ariagno R.L., Prober C.G. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 325(1):1991;24-29
102. Turner R.B., Wecker M.T., Pohl G., et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 281(19):1999;1797-1804